AIIMS study finds catheter infections in hospital widespread across India

New Delhi: Bloodstream infections acquired during a hospital stay due to the use of a catheter are prevalent across ICUs in India and are often caused by microbes having a high level of antibiotic resistance, according to a study led by the All India Institute of Medical Sciences, New Delhi.

Antibiotic resistance — in which antibiotic drugs are rendered ineffective because disease-causing microbes have become immune to them — can extend one’s hospital stay and treatment costs, adding stress to a public healthcare system.

Estimates published in The Lancet Global Health journal show that on average, around nine bloodstream infection events occur every 1,000 days that a central line — a catheter inserted in a patient’s large vein instead of an intravenous line — was in place in the intensive care units (ICUs) of Indian hospitals.

‘Central line-associated bloodstream infections’, or CLABSI, are preventable infections — often acquired from a hospital environment — and significantly contribute to illness and death in low- and middle-income countries, including India.

The researchers said that tracking rates of bloodstream infections in ICUs can help countries develop preventive measures suited to a healthcare system.

However, setting up a surveillance that systematically tracks infections due to catheter use or other hospital-acquired infections calls for a significant amount of resources and is a challenge in low- and middle-income countries, including India, they said.

The team analysed data from 200 intensive care units received by the Indian Healthcare-Associated Infections (HAI) surveillance network from 54 hospitals across the country over a period of seven years.

“During the surveillance period from May 1, 2017, to April 30, 2024, 8,629 laboratory-confirmed CLABSI events, 3,054,124 patient-days and 977,052 central line-days were recorded. The overall pooled CLABSI rate was 8.83 per 1,000 central line-days,” the authors wrote.

Highest rates of bloodstream infections linked to central line catheter use were seen to occur during 2020-21, coinciding with the Covid-19 pandemic, which the researchers said may be due to overwhelmed ICUs, staff shortage and compromised infection prevention measures.

The study — first large-scale observational one, providing a standardised surveillance report of CLABSI in India — provides a valuable opportunity for a quality improvement-based approach for the reduction of CLABSI, the authors said.

Related Posts

Almost 85% of overcharged amount claimed by NPPA yet to be recovered

New Delhi: India’s drug price monitoring and enforcing authority, the National Pharmaceutical Pricing Authority (NPPA), has almost 85 per cent of the amount it demanded from the pharma industry on…

Jharkhand’s Blood Scandal: Govt Suspends Officials, Launches Probes Amid Calls for NAT Testing Mandate

Ranchi–  In a heartbreaking breach of medical trust, five thalassemia-afflicted children in Jharkhand’s West Singhbhum district have tested HIV-positive after receiving contaminated blood transfusions at Chaibasa Sadar Hospital, exposing glaring…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives

Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives

Health dept cracks down on ‘Sojat’ henna fraud by pvt cos

Health dept cracks down on ‘Sojat’ henna fraud by pvt cos

BDMAI’s e-marketing portal to promote Indian pharma products and services

BDMAI’s e-marketing portal to promote Indian pharma products and services

FIR against pharma dealer for supplying dubious snake antidote to govt

FIR against pharma dealer for supplying dubious snake antidote to govt

Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India